Background Breast cancer is the second leading cause of death from cancer in women in
sub-Saharan Africa, yet there are few well characterised large-scale survival studies with …

The current levels of breast cancer in African women have contributed to the high mortality
rates among them. In South Africa, the incidence of breast cancer is also on the rise due to …

Background Most cancers in sub-Saharan Africa (SSA) are diagnosed at advanced stages,
with limited treatment options and poor outcomes. Part of this may be linked to various …

Abstract Background South Africa's public healthcare system is better equipped to manage
breast cancer than most other SSA countries, but survival rates are unknown. Methods A …

Background The most effective treatment for advanced AIDS-associated Kaposi sarcoma is
paclitaxel or pegylated liposomal doxorubicin (PLD); neither is routinely used in sub …

Purpose The South African HIV Cancer Match (SAM) Study is a national cohort of people
living with HIV (PLWH). It was created using probabilistic record linkages of routine …

Persons with HIV-associated Kaposi's sarcoma (KS) experience three co-existing
stigmatizing health conditions: skin disease, HIV, and cancer, which contribute to a complex …

The problem of antibiotic-resistant strains has become a global public issue; antibiotic
resistance not only limits the choice of treatments but also increases morbidity, mortality and …

Accurate survival estimates are needed for guiding cancer control efforts in sub-Saharan
Africa, but previous studies have been hampered by unknown biases due to excessive loss …

Background Médecins Sans Frontières is supporting comprehensive HIV care and treatment
for Kaposi Sarcoma (KS) in Guinea, where antiretroviral coverage is low and access to KS …